Mendelian randomization (MR) is a valuable tool for detecting evidence of causal relationships between pairs of traits. Opportunities to apply MR are growing rapidly as the number of genome-wide association studies (GWAS) with publicly available summary statistics grows. Unfortunately, existing MR methods are prone to false positives caused by pleiotropic variants. Correlated pleiotropy, which arises when genetic variants affect both traits through a heritable shared factor, is a particularly challenging problem and is not addressed by most existing methods. Additionally, most MR methods only use genome-wide significant loci, which can limit power and introduce bias. We propose a new method (Causal Analysis Using Summary Effect Estimates; CAUSE) that uses genome-wide summary statistics to identify patterns that are consistent with causal effects, while accounting for pleiotropic effects, including correlated pleiotropy. We demonstrate in simulations that CAUSE is much better at controlling false positive rate in the presence of pleiotropic effects than other methods. We apply CAUSE to study relationships between pairs of complex traits and between blood cell composition and autoimmune disorders. We find that CAUSE detects causal relationships with strong literature support, including an effect of blood pressure on heart disease risk that is not found using other methods. Our results suggest that many pairs of traits identified as causal using alternative methods may be false positives driven by pleiotropic effects.
Introduction
Inferring causal relationships between traits is important for understanding the etiology of disease and designing new treatments. However, inferring causal relationships is also hard. Randomized trials are considered the gold standard, but are expensive and sometimes impossible. Observational studies are cheaper and easier, but associations measured in observational studies may be biased by confounding and reverse causality.
Mendelian randomization (MR) is a potentially-powerful approach to studying causal relationships using data from observational studies. The key idea of MR is to treat genotypes as naturally occurring "randomizations" [1, 2, 3] . Suppose we are interested in the causal effect of trait M (for "Mediator") on trait Y . Under certain assumptions, summarized in Figure 1 , the associations of a genetic variant G j with traits M and Y will satisfy
where β Y,j is the association of G j with Y , β M,j is the association of G j with M and γ is the causal effect of M on Y . This relationship is the core of simple MR methods. Many methods based on Equation (1), including the commonly used inverse variance weighted (IVW) regression, first obtain estimates of β Y,j and β M,j for several genetic variants G j , and then estimate γ by regressing the estimates of β Y,j on the estimates of β M,j [4] . Unfortunately, the assumptions made by simple MR methods are often violated in practice, leading to non-zero estimates of causal effects when no causal relationship exists (false positives). Specifically, simple MR relies on the assumption that no variants are pleiotropic, meaning that no variants affect M and also affect Y through a pathway not mediated by M . Pleiotropy is a major source of false positives for simple MR methods, and therefore a major focus of ongoing MR research [3] . It is helpful to distinguish between two different types of pleiotropy: horizontal pleiotropy -where the pleiotropic effects on Y are uncorrelated with Of these two types of pleiotropy, horizontal pleiotropy is easier to account for because it only adds noise to the relationship in Equation (1) rather than inducing a systematic correlation between β Y,j and β M,j . Several methods have recently been developed to deal with this, including the weighted median estimator [5] , Egger regression [6, 7] , and several methods that rely on an outlier removal step including GSMR [8] and MR-PRESSO [9] . However, because these methods ignore correlated pleiotropy, they remain vulnerable to false positives in its presence (see Figure 2a ). Evidence from genetic correlation studies suggests that correlated pleiotropy is common [10] . Many traits, including pairs that are unlikely to be causally linked, share common genetic factors [10] . For example, many mental disorders are found to be genetically correlated, a pattern that is better explained by shared biological processes than by causal relationships [11] . Thus correlated pleiotropy is an important potential source of false positives in MR analyses [12, 13] .
Here we present a new MR analysis method that accounts for both horizontal and correlated pleiotropy. Causal Analysis Using Summary Effect Estimates (CAUSE) uses genome-wide summary statistics to identify pairs of traits that are consistent with a causal effect. The intuition is that, if M indeed causally affects Y then every variant affecting M will have a correlated effect on Y (Figure 2b ). This can be distinguished from correlated pleiotropy that leads to correlated effects for only a fraction of variants (Figure 2a ). Variants with strong effect on M but little effect on Y provide evidence against a causal effect of M on Y , even if other genetic variants show correlated effects. Methods like IVW regression, which assess average correlation, cannot take account of this, and can be mislead by even modest levels of correlated pleiotropy. CAUSE assess whether observed summary statistics for a pair of traits are consistent with a causal effect of M on Y by determining if effects are correlated for all variants or only a subset. Extreme cases of correlated pleiotropy, where a large proportion of variants affect M and Y through a heritable shared factor or pathway, may be impossible to distinguish from causal effects. Nonetheless, we demonstrate in simulations that CAUSE makes fewer false detections in the presence of correlated pleiotropy than existing methods. In applications to GWAS data for a large number of traits, CAUSE identifies a smaller number of trait pairs as consistent with causal effects than methods that do not account for correlated pleiotropy. Many of the pairs that CAUSE does detect have a plausible causal connection.
In addition to allowing for pleiotropic effects, CAUSE has two other important differences from simple MR methods. First, it uses information at all variants, rather than only the variants most strongly associated with M . This can increase power when the GWAS for trait M has low power. Second, when there is evidence of correlated pleiotropy, CAUSE can identify which variants most likely act through a shared factor. This can be useful for elucidating the biological mechanisms driving genetic correlation of related traits. Figure 2 : Simulated data illustrating (a) the pattern induced by a shared factor (correlated pleiotropy) and (b) the pattern induced by a causal effect. In both plots, effect size estimates are indicated by points. Error bars around points have length 1.96 times the standard error on each size. Only variants that are strongly associated with M (p < 5 · 10 −8 ) are shown. (a) Summary statistics are simulated for two traits with no causal effect. 15% of variants are associated with a shared factor that affects both traits (triangles). Although there are many variants associated with M and not with Y , the IVW estimator (dotted line) is significantly different from zero (p = 0.01). (b) Summary statistics are simulated under a model where M causally affects Y . Here every variant associated with M is also associated with Y and the effect sizes are correlated.
Results

CAUSE models horizontal and correlated pleiotropy
We use effect estimates and standard errors from GWAS of traits M and Y to assess whether the data are consistent with a causal effect of M on Y . In most MR methods, variants with strong associations with M are pre-selected and assumed to follow the causal diagram in Figure 1 . Our proposal, illustrated in Figure 3 , differs in three ways. First, we use all variants genome-wide and model uncertainty about the effect of each variant on M . Second, we allow every variant to exhibit horizontal pleiotropy. This is modeled as an effect, θ j , of variant G j on trait Y that is uncorrelated with the effect of G j on M . Third, we allow a subset of variants to exhibit correlated pleiotropy. We assume that a small proportion of variants, q, follow the causal diagram in Figure 3b , affecting M and Y through an unobserved heritable shared factor, U . The remaining variants are assumed to follow the causal diagram in Figure 3a , which is the same as the diagram in Figure 1 with the addition of a horizontal pleiotropic effect.
Under this model, the relationship between β Y,j and β M,j is
where Z j is an indicator that is 1 if G j affects U and 0 otherwise, and η is the effect of U on Y . This relationship is an extension of Equation (1) that includes terms allowing for both types of pleiotropic effect. We assume that q is small, so that Z j is equal to 0 for most variants (see Methods). We see in Equation 2 that, if there is no causal effect (γ = 0) and no variants affect a shared factor (q = 0), then β Y,j and β M,j are uncorrelated for all variants. If γ = 0 and q and η are non-zero, then β Y,j and β M,j are correlated for the small subset of variants with Z j = 1. This is the pattern observed in Figure 2a . If there is a causal effect (γ = 0), β Y,j and β M,j are correlated for all variants (Figure 2b ). We include every variant genome-wide in this model, but assume that θ j and β M,j are equal to zero for most variants. This allows us to model uncertainty about variant effects, avoid pre-selection, and gain power from variants with weak evidence of association with M (see Methods). The effect of G j on M is mediated by U . We have assumed that U is scaled so that its effect on M is 1. This makes the effect of G j on U equal to the effect of G j on M , β M,j . The effect of U on Y is equal to η, an unknown parameter. G j can affect Y through three pathways: through θ j , through the causal effect of M on Y , and through the effect of U on Y .
We assess whether estimates of β M,j and β Y,j obtained from GWAS are consistent with a causal effect by comparing two nested models: the sharing model which has γ fixed at 0 allowing for only pleiotropic effects and no causal effect and the causal model in which γ is a free parameter. We compare the models using the expected log pointwise posterior density (ELPD; [14] ), which measures how well the posterior distributions of a particular model are expected to predict a new set of summary statistics, for example, if both GWAS were repeated with new samples (see Methods). We estimate the difference in ELPD between the two models, ∆ELPD and the standard error of the estimator to generate a z-score and a corresponding one-sided p-value. A large, positive z-score provides support for the causal model, indicating that the data are consistent with a causal effect.
For computational simplicity, we use a likelihood for independent variants and prune variants for LD before estimating posterior distributions and computing test statistics. The effects of LD are discussed in more detail in Supplementary Note Section 5.4. Numerical evaluations in Section 2.2 are conducted using data simulated with a realistic LD pattern and pruned using the same method applied to biological data in Sections 2.3 and 2.5.
The causal diagram in Figure 3b is related to the model used in the latent causal variable (LCV) method proposed by [13] . The connection between CAUSE and LCV is discussed in Supplementary Note Section 5.5. LCV, however, is conceptually different from CAUSE and other MR approaches. Rather than estimating and testing for causal effects of M on Y , LCV considers the proportion of heritability of each trait that is mediated by a heritable shared factor. This is summarized as the "genetic causality proportion" (GCP) which ranges from -1 to 1. Higher magnitude GCP indicates that the shared factor explains more genetic variation of one trait than the other, described as "partial causality" by [13] . GCP has no direct interpretation in CAUSE or other MR models and some non-causal scenarios have large magnitude GCP. In these scenarios, LCV produces misleading results if non-zero GCP is interpreted as evidence of a causal relationship (see Supplementary Note Section 5.5).
CAUSE can distinguish causality from pleiotropic effects in simulations
We simulate summary statistics with realistic LD patterns to assess CAUSE in a variety of scenarios and compare performance with other MR methods. The power of trait M and Y GWAS can influence performance of all methods, so we consider low power (sample size 12,000) and a high power (sample size 40,000) settings for both traits. Both traits are simulated with a polygenic trait architecture -an average of 1,000 effect variants contribute to a total heritability of 0.25. Under the low and high power settings respectively, a median of 8 and 107 independent variants are genome-wide significant at p < 5 · 10 −8 . Variant effects on trait Y are generated from the relationship in Equation (2) and effect estimates are computed from true variant effects and the variant correlation (LD) structure using results of [15] (see Methods). The LD structure for simulated data is estimated from the 1,000 genomes CEU samples [16] .
We compare CAUSE to five MR methods: IVW regression [4] , Egger regression [6] , GSMR [8] , MR-PRESSO [9] , and the weighted median method of [5] . These methods require pre-selection of variants with strong evidence of association with trait M . We followed the typical practice of selecting variants with p < 5 · 10 −8 for association with M and pruning for LD so that no pair of variants has pairwise r 2 > 0.1.
We first evaluate the robustness of each method to correlated pleiotropy by simulating data with no causal effect and a proportion q = 0 − 50% of variants acting through a shared factor ( Figure 4a ). In all settings, methods except for CAUSE have an elevated false positive rate in the presence of correlated pleiotropy (q > 0). CAUSE makes more false detections when q is large and the GWAS have higher power. This is expected because the data pattern resulting from a high proportion of shared variants is similar to the pattern that results from a causal effect. Nonetheless, in all settings and for all parameter values, CAUSE has substantially lower false positive rates than any other method.
We next compare the power of each method when there is a true causal effect of M on Y and no shared factor ( Figure 4b ). The causal effect size is parameterized by the proportion of Y heritability explained by the causal effect of M ,
= γ 2 (M and Y have equal heritability in these experiments). CAUSE has somewhat lower power than other methods in most settings. This is expected since CAUSE requires stronger evidence in order to conclude that the data are consistent with a causal effect. However, when the trait M GWAS has low power, CAUSE can achieve better power than other methods when causal effects are relatively large (at N M = 12, 000 and N Y = 40, 000). This is a result of using all variants genome-wide, rather than limiting only to those reaching genome-wide significance.
We note that the difference in performance of CAUSE and other MR methods cannot be explained simply by using a more stringent threshold to call causal effects under CAUSE. The CAUSE test statistic is better able to distinguish data simulated with a causal effect from data simulated with 30% correlated pleiotropy ( Figure 4c ). Remarkably, CAUSE is also better able to distinguish data simulated with a causal effect from data with no causal effect and no correltaed pleiotropy (Supplementary Figure S2 ).
Identifying causal relationships between pairs of complex traits
We use CAUSE to analyze pairwise relationships for 20 traits with summary statistics available from published GWAS, ( Supplementary Table S1 ). These include anthropometric traits, cardio-metabolic biomarkers (e.g. blood pressure, lipids) and complex diseases such as coronary artery disease (CAD) and type 2 diabetes (T2D). For each pair of traits we use CAUSE to compare the sharing model with the causal model. To account for multiplicity, we use the Benjamini-Hochberg procedure [17] to convert CAUSE p-values to q-values [18] .
We analyze the same data using IVW regression, Egger regression [6] and MR-PRESSO [9] to test for a causal effect of M on Y for each pair of traits. As with CAUSE, p-values for each method are converted to q-values. For all three methods, we include variants with p < 5 · 10 −8 and mutual r 2 < 0.1 in the GWAS of trait M (see Methods). The results of these methods are qualitatively similar (Supplementary Figure S4 ) so we limit our discussion to comparing CAUSE and IVW regression.
Using CAUSE, 49 pairs of traits are significant at q < 0.05, while IVW regression identifies 104 pairs as significant at the same threshold ( Figure 5 ). Seven pairs detected by CAUSE are not detected by IVW. Four of these are effects of blood pressure phenotypes on CAD risk. The others are an effect of systolic blood pressure on stroke risk, an effect of birth length on adult height, and an effect of fasting glucose on type 2 diabetes risk. Effects of blood pressure on CAD are plausibly real causal effects based on evidence from clinical trials [19] . The failure of IVW regression to detect these effects is likely due to low power in the GWAS of the blood pressure phenotypes. The four phenoytpes have between five and nine independent variants reaching genome-wide significance. However, there are many sub-threshold variants that contribute to the CAUSE test statistic to bolster evidence for a causal effect ( Figure 6a ).
Many pairs of traits detected by both methods are plausible effects such as BMI and LDL cholesterol on CAD risk ( Figure 6b ) and blood pressure on stroke risk. Others are very closely related phenotypes such as body fat percentage and BMI. In many of these cases, CAUSE indicates that the data are consistent with causal effects in both directions. However, we interprete of these results to indicate that almost all effect variants are shared rather than that the traits are mutually causal (see Discussion). IVW regression detects a large number of trait pairs that are not detected by CAUSE. Many of these may be false positives driven by variants affecting shared factors. For example, IVW detects significant causal effects of CAD on a number of traits, some of which are highly implausible, e.g. CAD effect on birth weight ( Figure 5 ). Other examples include effects of blood pressure on BMI, and total cholesterol and triglycerides on adult height. CAD and LDL cholesterol provide an illustrative example of how correlated pleiotropy can induce errors using IVW regression and how these are avoided by CAUSE. Both IVW and CAUSE detect an effect of LDL cholesterol on CAD risk (IVW q-value 3.4 · 10 −30 ; CAUSE q-value 3.2 · 10 −5 ; Figure 6b ), which is consistent with the current predominant view of the relationship between LDL and CAD risk [20] . However, IVW also detects a causal effect in the opposite direction, of CAD on LDL cholesterol (Figure 6c ), which is most plausably a false detection. This occurs because some of the variants associated with CAD are acting through LDL and therefore have correlated effects on both traits, leading to the false finding by IVW. CAUSE avoids this problem because there are many variants that affect CAD and are independent of LDL. These variants provide evidence against a causal effect of CAD on LDL and make large contributions to the CAUSE test statistic (Figure 6c ).
CAUSE does not entirely avoid likely false detections. For example, recent research suggests that the signal of an effect of HDL cholesterol on coronary artery disease (CAD) is driven by variants that affect both LDL and HDL cholesterol [21, 22] . This effect is detected by both IVW regression and CAUSE. This is likely driven by a very high proportion of shared variants, which is hard to differentiate from a causal effect. Under the sharing model, CAUSE estimates that 54% of HDL variants are shared with CAD (Supplementary Figure S3 ).
The CAUSE results suggest that many pairs of traits share variants that act through a common pathway. Under the sharing model, the posterior median of q exceeds 10% for 114 trait pairs (the prior median is 7%; Supplementary Figure S3 ). These include 78 (75%) of the trait pairs detected as significant by IVW regression. This overlap is expected because a positive IVW result indicates that top trait M variants have, on average, correlated effects on Y . High levels of sharing are also suggested by large correlation estimates made by cross-trait LD-score regression [23] (Supplementary Figure S5 ). However, in many cases, CAUSE results suggest that these patterns can be explained by a shared factor rather than a causal effect. Together, these results suggest that shared factors may be major contributors to false positives using traditional MR methods.
CAUSE provides insights on biological mechanisms driving genetic correlation of trait pairs
CAUSE posterior estimates under the sharing model can yield insights into the relationship between M and Y when correlation is driven by a shared factor rather than a causal effect. CAUSE estimates a posterior probability of acting through U for each variant, under the sharing model. Identifying variants that act through a shared factor may help identify biological processes that influence both traits.
To illustrate, we consider the relationship between birth weight and T2D risk, treating birth weight as the mediator. IVW regression identifies an average negative correlation of effect sizes between the two traits (IVW q-value 7 × 10 −4 ), however, CAUSE does not find the data to be consistent with a causal effect (CAUSE q-value 0.32; Figure 6d ). To identify candidate genes and pathways that mediate sharing between these traits, we first assign variants to genes using cis-eQTLs from the GTEx project. Variants that are not cis-eQTLs are annotated to the nearest gene. We then test gene sets defined in the Gene Ontology database [24, 25] for enrichment of genes associated with variants that have a high posterior probability of acting through U (see Methods). The most enriched gene sets include those related to cell division, to PIP2 binding, and to the integrin complex (Supplementary Table S2 ). The integrin pathway results are driven by several integrin subunit genes ( Supplementary Table S3 ), one of which, ITGA1, is among the top loci associated with related traits including T2D, fasting insulin, β-cell function and glucose tolerance [26] .
Links between auto-immune disease and blood cell counts
There are a growing number of GWAS for intermediate or biomarker traits. Relationships between these traits and clinical outcomes are appealing targets for MR studies because biomarkers may be more likely . Although the average correlation in effect estimates significantly different from zero, variants with large effects on CAD and no effect on LDL prevent CAUSE from making a false discovery. d) Birth weight (M ) and type 2 diabetes (Y ). IVW regression results suggest a causal effect while CAUSE results indicate that the data may be explained by a shared factor, because many variants (green) contradict the ovreall negative correlation in effect sizes.
than complex traits to causally affect disease risk, and may be accessible as drug targets. We use CAUSE to search for evidence of causal relationships between 13 measures of blood cell composition and eight auto-immune diseases with publicly available summary statistics ( Supplementary Table S4 ). At an FDR threshold of 0.05, only 2 of the 104 pairs of traits are found to be consistent with a causal effect using CAUSE ( Supplementary Figures S6 and S7) . These are positive effects of eosinophil count on asthma and allergy risk, both of which are supported by literature [27] . IVW regression also identifies these pairs at the same significance threshold. In addition IVW regression detects 20 other pairs (Supplementary Figure S6) , including causal relationships of red cell distribution width (RDW) and mean corpuscular hemoglobin (MCH) on multiple traits. Since RDW and MCH have no known direct role in autoimmunity, these results may be false positives due to sharing of variants that act through a common factor. Consistent with this, CAUSE estimates more than 10% of variants to act through a shared factor for 13 of the trait pairs found to be significant by IVW regression (Supplementary Figure S7 ).
Discussion
We have introduced CAUSE, a new approach to MR analysis that accounts for horizontal and correlated pleiotropy. In simulations CAUSE avoids false positives in the presence of pleiotropic effects that bias other methods. With highly powered GWAS, CAUSE tends to be more conservative than other methods, requiring more evidence for a causal effect. However, when GWAS are under-powered, CAUSE improves power by using all variants genome-wide rather than relying only on highly significant associations. Previous authors have identified horizontal pleiotropy as a pervasive phenomenon [9] that may adversely impact MR analyses. Our analyses demonstrate that correlated pleiotropy is also common and may explain a large fraction of positive results obtained using other MR methods.
Caution must be used when interpreting results of CAUSE, as well as any other MR method. CAUSE tests that the GWAS summary statistics for M and Y are consistent with a model in which every variant M effect variant has a correlated effect on Y . This pattern occurs when M has a causal effect on Y but can also occur in other circumstances. Notably, if most of the heritable variation of two traits is mediated by the same unobserved process, we expect to observe this pattern in both trait directions. This can be seen in our analysis of complex traits when CAUSE rejects the sharing model in both directions for pairs of traits like BMI and body fat percentage that are very closely related. With this in mind, it may be useful to test trait pairs in both directions and give more attention to effects that are seen in only one direction [12] .
CAUSE has several limitations that provide interesting future research directions. First, it is not curently possible to account for known shared factors or confounders when they are measured. For example, when comparing HDL level vs. heart disease risk, it may be desirable to control for the effect of LDL cholesterol on disease risk. Second, CAUSE models only a single shared factor, so it may not fully account for shared genetic components between two traits of interest. This problem is partially alleviated by the flexibility of the empirical prior distribution (see Methods). Finally, CAUSE simply prunes variants for LD rather than explicitly modeling variant correlation. This helps ensure that the problem is computationally tractable, however, using only one variant per LD block may lead to loss of information.
Methods
CAUSE model for GWAS Summary Statistics
We use effect estimates and standard errors measured in GWAS of traits M and Y (summary statistics) to look for evidence of a causal effect of M on Y . Let (β M,j ,ŝ M,j ) and (β Y,j ,ŝ Y,j ) be effect estimates and standard errors at variant G j (j = 1, . . . , p) for traits M and Y respectively. Let β M,j and β Y,j be the true marginal associations of G j with M and Y . We model effect estimates as normally distributed given the true effects, allowing for global correlation that can result from overlapping GWAS samples. We model
where where S j (ρ) = ŝ 2 M,j ρŝ M,jŝY,j ρŝ M,jŝY,jŝ 2 Y,j and N 2 (x; µ, Σ) is the bivariate normal density with mean µ and variance Σ evaluated at x. This model implicitly assumes thatŝ M,j andŝ Y,j are measured without error. The correlation term, ρ, which accounts for the effects of sample overlap, is estimated empirically (Supplementary Note Section 5.1).
In the CAUSE model, a proportion, q of variants exhibit correlated pleiotropy, modeled as an effect on a shared factor, U (Figure 3b ). The remaining proportion 1 − q of variants are independent of U ( Figure 3a ). All variants may have horizontal pleiotropic effects, θ j on Y that are uncorrelated with their effects on M . Let Z j be an indicator that variant j effects U . Then,
where η is the effect of U on Y and U is scaled so that the effect of U on M is 1. Note that if there are no horizontal or correlated pleiotropic effects, then Equation (5) reduces to β Y,j = γβ M,j , which is the relationship assumed by simple MR approaches such as IVW regression. We substitute the right side of Equation (5) into Equation 3 and integrate out Z j to obtain
The parameters of interest in the CAUSE model are γ, η, and q. Rather than estimating individual variant effects β M,j and θ j , we model their joint distribution empirically and integrate them out to obtain a marginal density forβ M,j andβ Y,j . We model β M,j and θ j as draws from a mixture of bivariate normal distributions. This strategy is based on Adaptive Shrinkage (ASH) approach for modeling univariate distributions Stephens2016 and provides a flexible unimodal distribution with mode at (0, 0). We model p (β M,j , θ j |π 0 , . . . , π K , Σ 0 , . . . ,
where Σ 0 , Σ 1 , . . . , Σ K are a set of pre-specified covariance matrices of the form Σ k = σ 2 k,1 0 0 σ 2 k,2 , and π 0 , . . . , π K are a set of mixing proportions that sum to 1. The set of parameters Ω = {π 0 , . . . , π K , Σ 0 , . . . , Σ K } are estimated from the data along with ρ in a single pre-processing step (Supplementary Note Section 5.1).
Integrating the distribution of β M,j and θ j out of Equation (6), we obtain
where A(x) = 1 0 x 1 . Treating variants as independent, we obtain a joint density for the entire set of summary statistics as a product over variants. We place independent prior distributions on γ, η, and q, 
Accounting for Linkage Disequilibrium
We treat variants as independent when we compute the joint density of summary statistics. In reality, variants are correlated due to linkage disequilibrium (LD). We define the LD-transformed effects β *
where R is the variant correlation matrix matrix and S M and S Y are diagonal matrices with elements (s M,j ) and (s Y,j ) Zhu2016a. We assume that the correlation structure is the same in both GWAS. The pair of estimates (β M,j ,β Y,j ) can be approximated as normally distributed with mean (β * M,j , β * Y,j ) and variance S(ρ). If the relationship in Equation (5) holds for direct effects and either M effects are sparse relative to LD structure (most M effect variants are independent) or q is small, then the relationship between the LD-transformed effects is
where θ * = S Y RS −1 Y θ (see Supplementary Note Section 5.4). In this case, the mean relationship for summary statistics at a single locus is the same with or without LD and Equation (6) and (8) remain valid for variants in LD if β M,j and θ j are replaced with β * M,j and θ * j . Correlations among variants can affect the joint density of all summary statistics, which we compute as a product of the densities at each variant. To account for this, we use a subset of variants with low mutual LD (r 2 < 0.1 by default), prioritizing variants with low trait M p-values ito improve power.
If M effect variants are dense relative to LD structure and q is large, LD can induce a positive correlation between Y and M effect estimates for all variants even when there is no causal effect, leading to false positives (see Supplementary Note Section 5.4).
Prior Distributions for γ, η, and q
We place normal prior distributions with mean zero on γ and η. We find in simulations that results are robust to different choices of prior variance for γ and η, as long the same value is used for both parameters (Supplementary Note Section 5.2). Since the magnitude of a possible causal effect is difficult to know a priori due to differences in trait scaling and covariate adjustment across GWAS, we use the data to suggest a prior variance (Supplementary Note Section 5.2).
By default, and in all analyses presented here, we use a Beta(1, 10) prior distribution for q. This distribution gives a prior probability of 0.001 that q > 0.5 and 0.056 that q > 0.25. In our R implementation, the parameters of the Beta distribution can be adjusted by the user to reflect different prior beliefs about the size of q. For example, when one uses a stronger prior with prior mean closer to 0, q is restricted to be nearly equal to 0. In the limit, this reduces to standard MR, while still accounting for polygenicity of traits, sample overlap, and horizontal pleiotropy.
Model Comparison Using ELPD
To determine whether GWAS summary statistics are consistent with a causal effect of M on Y we compare a model in which the causal effect is fixed at zero (the partial sharing model ) to a model that allows a non-zero causal effect (the causal model ). To compare the fit of these models, we estimate the difference in the expected log pointwise posterior density (∆ELPD) Vehtari2016. The ELPD measures how well the posterior distributions estimated under a given model are expected to predict a hypothetical new set of summary statistics obtained from GWAS of M and Y in different samples.
Let Θ be the set of parameters (γ, η, q). Let p C (Θ|Data) and p S (Θ|Data) be the posterior density of Θ given the observed summary statistics under the causal model and partial sharing model respectively. Let y j denote a new observation of (β M,j ,β Y,j ,ŝ M,j ,ŝ Y,j ). The ELPD for model m ∈ {C, S} is
where p(y j |Θ, Ω, ρ) is given in Equation (8) and p true is the probability density under the true data generating mechanism. If ∆ELPD = ELPD C − ELPD S is positive, then the posteriors from the causal model predict the data better so the causal model is a better fit. If ∆ELPD≤ 0, then the partial sharing model fits at least as well, indicating that the data are not consistent with a causal effect. We estimate ∆ELPD and a standard error of the estimator using the Pareto-smoothed importance sampling method described by [14] and implemented in the R package loo. We then compute a z-score,
, that is larger when posteriors estimated under the causal model fit the data better than the posteriors estimated under the partial sharing model. We compute a one-sided p-value by comparing the z-score to a standard normal distribution. The p-value estimates the probability of obtaining a z-score larger than the one observed if the true value of ∆ELPD were less than or equal to zero.
Generating Simulated Summary Statistics
To create data with a realistic correlation structure, we estimate LD for 19,490 HapMap variants on chromosome 19 in the CEU 1,000 Genomes population using LDShrink ( [28] ; https://github.com/stephenslab/ ldshrink) and replicate this pattern 30 times to create a genome sized data set of p = 584, 700 variants. We set the heritability of each trait h 2 M and h 2 Y , the sample size for each GWAS N M and N Y , and the expected number of effect variants m M and m θ . Additionally, we set γ, η, and q and generate effect estimates from the CAUSE model in Equation (5) . We note that m θ is the expected number of variants with θ j = 0, rather than the expected number of variants with non-zero effect on Y .
We simulate an effect estimate and standard error for each variant using the following procedure. First, standardized effectsβ M,j andθ j are drawn from a mixture distribution:
whereβ M,j andθ j are standardized effects defined as defined asβ M,j = β M,j 2f j (1 − f j ) andθ j = θ j 2f j (1 − f j ) and f j is the allele frequency n the 1,000 Genomes CEU population of variant j. Variances σ 2 M and σ 2 θ are chosen to give the desired expected heritability as
Mixing parameters are π M = m M /p and π θ = m θ /p. Note that γ 2 h 2 M /h 2 Y is the proportion of trait Y heritability mediated by the causal effect and qη 2 h 2 M /h 2 Y is the proportion of trait Y heritability mediated by U .
Second, standardized effects are converted to non-standardized effects and standard errors are computed as as s ·j = 1 (2 * N· * f j * (1−f j ) , where · may be M or Y . Third, Z j are drawn from a Bernoulli(q) distribution and true effects β γ,j are computed using Equation (5) . Finally, effect estimates are simulated from true effects asβ
where S · is the diagonal matrix of standard errors and R is the variant correlation matrix Zhu2016a. Simulations can be replicated using the online tutorial (https://jean997.github.io/cause/simulations. html).
Exiting MR Methods
We compare the performance of CAUSE in simulated data with five alternate MR methods. These are implemented as follows.
• IVW regression: Implemented by us in R.
• Egger regression: Implemented by us in R.
• MR-PRESSO: Performed using MRPRESSO R package ( [9] , https://github.com/rondolab/MR-PRESSO) with outlier and distortion tests.
• GSMR: Performed using gsmr R package ( [8] , http://cnsgenomics.com/software/gsmr/) with the Heidi outlier test, default threshold 0.01, and minimum number of instruments lowered to 1.
• Weighted median: Performed using R code available in [29] .
Gene set enrichment analysis with shared variants of trait pairs
When CAUSE results indicate that summary statistics for a pair of traits are not consistent with a causal effect, but there is a substantial amount of correlated pleiotropy (i.e. the posterior distribution of q is large), CAUSE posterior estimates can be used to identify which pathways contribute to this pleiotropy. We use a four step procedure to identify pathways enriched for shared variants. First, we assign variants to genes. We include only variants with p-value for association with M < 0.001, pruned for LD with a threshold of r 2 < 0.1. These are the variants used to compute the CAUSE posterior distributions. Variants that are significantly associated with gene expression (q-value < 0.05) in any of 48 tissues in the GTEx catalog (cis-eQTLs) are assigned to the genes they are associated with. Variants that are not cis-eQTLs are assigned to the nearest gene. Some variants may be assigned to multiple genes. Second, genes are assigned to gene sets defined by the Gene Ontology database (http://geneontology.org, [24, 25] ). Variants are assigned to gene sets transitively. Third, for each gene, i we compute the median posterior probability of acting through U for all variants assigned to that gene, denoted P i . Finally, for each gene set j, we assess evidence for an enrichment of genes with variants that are likely to be shared using logistic regression. We model logit(Gene i in set j) = α 0,j + α e,j P i + ij .
For each pathway we estimate α e,j and α 0,j using logistic regression and test the hypothesis that α e,j is equal to zero. We use a Benjamini-Hochberg correction to account for multiple testing.
5 Supplementary Note (Appendix) 5 .1 Empirical Parameter Estimation CAUSE analysis involves two steps (see Supplementary Figure S1 ). We first empirically estimate ρ, the global correlation of summary statistics that can result from GWAS sample overlap and the parameters that define the joint prior distribution of β M,j and θ j . We do this in two sub-steps: 1) Select a panel of candidate covariance matrices Σ 0 , . . . , Σ K and 2) Fix γ = η = 0 and calculate the maximum a posteriori (MAP) values of ρ and π 0 , . . . , π K . The set of candidate covariance matrices should be large enough that a flexible joint distribution can be fit for β M,j and θ j , but not so large that evaluating the likelihood in (8) becomes burdensome. To choose this set, we first apply the Adaptive Shrinkage (ASH) method proposed by [30] to estimate the distributions of β M and β Y separately. Briefly, given a set of summary statistics for a single study, ASH estimates a sparse unimodal distribution for the marginal effects. This distribution is flexible and parameterized as a mixture of univariate normal distributions centered at 0. ASH uses the model
where ς 0 , . . . , ς L are a fixed grid of variances with ς 0 = 0. ASH estimates the mixing proportions 0 , . . . , L using a prior on that encourages more weight to be given to 0 , the proportion of effects equal to 0. Despite starting with a large number of candidate variances, ASH solutions tend to place most of the weight on only a few values. The resulting solution is sparse (most of the estimated effects are 0) and parsimonious (there are few components in the model with non-zero mixing proportion).
Let ς M,0 , . . . , ς M,l M and ς Y,0 , . . . , ς Y,l Y be the set of variances with non-zero weight in the ASH estimates for traits M and Y respectively. Because ASH encourages sparsity, in all cases ς M,0 = ς L,0 = 0. We construct the panel of candidate 2×2 covariance matrices in by taking all pairs of these variances as diagonal elements and setting the off diagonal elements to be 0. Thus if l M = 4 and l Y = 3, our method produces a set of (4 + 1)(3 + 1) = 20 candidate covariance matrices.
In the second step, we fix γ = η = 0 and calculate the MAP values of ρ and π 0 , . . . , π K . We use a Dirichlet(10, 1, . . . , 1) prior on π 0 , . . . , π K with π 0 corresponding to the covariance matrix of all zeros. This prior is the same prior used by default in ASH and encourages a sparse solution, however the weights may be adjusted by the user in the CAUSE software. We use a prior on z = tanh −1 (ρ) = log(1+ρ) 2(1+ρ) of z ∼ N (0, 0.25), which is a weak prior encouraging ρ to be close to zero. To calculate the MAP estimate, we use coordinate descent, alternating between optimization of ρ with π fixed and optimization of π with ρ fixed. As observed by [30] and others, maximization in π is a convex optimization problem that can be completed quickly. In practice, we find that convergence is usually reached within five iterations.
Prior Distributions for γ and η
In most cases, little prior information is available about the size of the causal or confounding effect. Differences in variable scaling and covariate adjustment across GWAS may make it difficult to predict even the magnitude of these effects. Fortunately, we find that CAUSE results are robust to a wide range in prior distributions for these parameters. We require that the same prior be used for γ and η. If this is not the case false positives can arise when the true shared factor effect is better represented by the prior on γ than the prior on η. We use normal prior distributions with mean 0 and variance σ 2 γη for γ and η. To assess the robustness of CAUSE to changes in σ 2 γη , we analyze data simulated from three scenarios using a range of values for σ 2 γη . The three scenarios include 1) a setting with a causal effect (γ = 0.2,η = 0, q = 0), 2) a setting with no causal effect but some correlated pleiotropy (γ = 0,η = 0.2,q = 0.3), and 3) a setting with neither a casual effect or correlated pleiotropy (γ = 0,η = 0,q = 0) (See Supplementary  Table ? ?). We analyze simulated data using three values of σ 2 γη . These are chosen so that 0.2, the value of γ in setting 1 and the value of η in setting 2 is at the 80th, 65th, and 51st quantile of the N (0, σ 2 γη ) distribution. We compare the posterior median estimates for γ, η, and q under the full and sharing models as well as p-values comparing the two models across different values of σ 2 γη . The Pearson correlation in p-values was greater than 0.99 for all settings and between all pairs of prior variances. The correlation in posterior medians was higher than 0.9 for all parameters and all settings except for estimates of q in setting 1. These had a somewhat lower correlation (minimum correlation 0.63). However, in all cases the posterior median of q in the causal model was between 0.02 and 0.06. These results demonstrate that very similar inference can be obtained using a range of prior distributions for γ and η.
By default, σ 2 γη is chosen using the data. We use a set of variants with trait M p-value < 10 −3 and computeγ max = max |β 2 β 1 |. This is the largest magnitude of causal estimate that could be achieved using only one variant. We then choose σ γη so that the prior probability that γ or η has magnitude larger than γ max is 0.05.
Approximating posteriors of γ, η, and q
We use an adaptive variation of a simple grid posterior approximation [31] to approximate the joint posterior distribution of γ, η, and q. To compute this approximation, we begin with initial bounds on γ and η of (−1, 1). These will be adaptively expanded as needed. The bounds on q are fixed at (0, 1).
The approximation proceeds as follows:
1. The domain of (γ, η, q) is divided into a coarse set of cubes. The approximate posterior probability of each cube is computed by approximating the likelihood within the cube as constant and equal to the likelihood at the midpoint of the cube.
2. After the first rough approximation, the bounds of γ and η are expanded so that less that 0.001 of the posterior mass falls in the cubes closest to the boundary. These bounds are then fixed.
3. The grid is then iteratively refined until no cube contains more than 1% of the posterior density. At each iteration, all cubes containing more than this are subdivided into nine smaller cubes and the posterior is re-estimated.
Effects of LD
In Sections 2.1 and 4.2 and we briefly describe the effects of LD. Here, we discuss these in greater details. CAUSE relies on two assumptions. The first is that the joint likelihood of all pairs of summary statistics can be factorized into the product of the likelihood for each variant. Variants in LD are not independent, however, by pruning variants so that the set is nearly independent, we can approximate this condition. The second is that
Without LD, this is a consequence of Equation (5) and the assumption thatβ M,j andβ Y,j are unbiased estimators for β M,j and β Y,j . In the presence of LD, the effect estimateβ ·,j (· may be M or Y ) is not an estimator of β ·,j , but instead estimates β ·,j plus a contribution from each of the neighbors of variant j. Using results from [15] ,
where r jk is the correlation between variant j and variant k and we assume that the LD structure in the samples used for the two GWAS are the same. We refer to β * ·,j as the LD-transformed effects. Note that if allele frequencies are the same in the two GWAS populations then s M,j = cs Y,j where c is a constant depending on sample size. Thus
We now derive Cov(β Y,j ,β M,j |Z) in the presence of LD, where Z is a vector with jth element equal to Z j . We assume that direct effect are independent so Cov(β M,j , β M,k ) = 0 if j = k and Cov(β M,j , θ j ) = 0 for all j and k and thatβ M,j andβ Y,j are independent conditional on β * M,j and β * Y,j . Then
Note that
Suppose that the variant correlation structure can be decomposed into independent LD blocks and that there is at most one M effect variant per block. If this variant has index k then, for any variant in the block
This means that, if Z k = 1, then variant k induces correlation between effect estimates for other variants in the block, even when γ = 0. However, if we use only one variant per LD block to estimate parameters then there is no distortion in the proportion of correlated variants. If γ = 0, then the proportion of variants with correlated effect estimates will be equal q, the proportion of true effect variants acting through U . In this case, CAUSE will not have an increased false positive rate but may have lower power if the variants selected to use in estimation are far from the true causal variants. To maximize power, we prune for LD prioritizing variants with low trait M p-values.
More generally, a block may contain multiple causal variants of M , with some acting on U (shared variants) and others not. Equation 17 suggests that any shared variant will induce non-zero correlation of β Y,j andβ M,j even if γ = 0. The presence of non-shared variants in a block reduces the correlation, but will not eliminate it. When M is highly polygenic and q is large, the proportion of blocks containing at least one shared variant will be large relative to the true proportion of shared variants, and this may lead to inflated estimates of q and high false positive rates. CAUSE assumes that these settings are rare. However, our simulations with realistic LD demonstrate that LD may have a limited impact on the performance of CAUSE in terms of false positive rates. [13] propose an approach to identifying pairs of traits with causal relationships that uses a latent causal variable (LCV) model. This model is similar to the CAUSE model ( Figure 3 ) with γ = 0. Rather than explicitly modeling both correlated pleiotropy and a causal effect, the LCV model includes only a shared factor (U in the CAUSE model) and estimates the "genetic causality proportion" (GCP). The GCP reflects the relative proportions of heritability of each trait that are explained by a shared factor. A causal effect (with no additional correlated pleiotropy from other sources) is equivalent to a model in which all variants act through a shared factor. In this case, the GCP is equal to 1 or -1 depending on the directionality of the effect.
Connections with LCV
LCV estimates the GCP and computes a test statistic testing whether GCP= 0. However, models with non-zero GCP are not necessarily causal. In fact, many non-causal models have large magnitude GCPs, so the LCV test cannot be interpreted as a test of causality. [13] use an estimated GCP larger than 0.6 to suggest a possible causal relationship, but this cutoff is somewhat arbitrary. Because the LCV model is similar to the CAUSE model with γ = 0, we can derive an expression for GCP in terms of CAUSE parameters under this condition. The LCV model uses two parameters q lcv M and q lcv Y , the square root of the proportions of trait M and Y heritability explained by the shared factor. Here we use the same trait M and Y notation used in our discussion of CAUSE for simplicity. In terms of CAUSE parameters these are
The GCP is then defined as
From this formula, we see that GCP is non-zero if η and q are both non-zero. For example, if the heritability of the two traits is equal, q = 0.3 and η = √ 0.05 then GCP= 0.55. From this we see that testing whether GCP= 0 is very different from testing whether γ = 0 as CAUSE and other MR methods do.
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Prior on π: Dirichlet(10, 1, . Figure S7 : Posterior estimates of q from the sharing model for blood cell and autoimmune triats (Section 2.5). The parameter q is the proportion of trait 1 variants that effect trait 2 through the confounder or shared factor. Shape indicates effect direction of U on Y (the sign of posterior median of η). Shaded symbols indicate that the ELPD test statistic favors the causal model at an FDR threshold of 0.05. Point size is proportionate to the posterior median of q under the sharing model. This value is also printed above each point. Points are shown only for pairs with posterior median of q greater than the prior median of q. Table S3 : Genes in the integrin pathway discussed in Section 2.4. Each gene is associated with only one variant. P i gives the posterior probability that each variant affects a factor shared by T2D and birth weight. For this pair of traits, the posterior median of q under the sharing model is 0.12.
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